Carbazochrome sodium sulfonate 25mg/5ml
Solution for injection
Hemorrhagic tendency (purpura etc.) due to decreased capillary resistance and increased capillary permeability.
Hemorrhage from skin, mucous membrane and internal membrane, hemorrhage at eyeground, nephrotic hemorrhage and metrorrhagia.
Abnormal bleeding during and after operation due to decrease of capillary resistance
Normal dose for adults is 25-100 mg daily, injection or infusion.
The dose should be up to the age and the severity of the disease.